Clinical evidence for cancer variants: BRAF in CIViC
How to pull clinical evidence for cancer variants of BRAF from CIViC with one BioQ query, with evidence levels, drugs and disease links as of 2026-11-06.
Blog
Worked examples from BioQ: genes, drugs, trials, structures and papers searched across 97 bio databases — with the real results, the sources and the exact query to repeat.
How to pull clinical evidence for cancer variants of BRAF from CIViC with one BioQ query, with evidence levels, drugs and disease links as of 2026-11-06.
CDK4 vs CDK6 in DepMap and drug data: 786 of 1178 cell lines depend on CDK4, 595 on CDK6, and four approved drugs are annotated to both genes.
A 2026 Cell Reports paper links HPV E2 to ATM activation; BioQ's DepMap, ChEMBL, Open Targets and TCGA data show where ATM stands as of 2026-11-06.
Connect the BioQ MCP server to Claude, ChatGPT or Cursor and run a FLT3 target and drug question in three calls; results are from data as of 2026-11-06.
A new phase 2 trial, NCT07582159, adds acalabrutinib to tafasitamab and venetoclax in CLL/SLL; BioQ shows its BTK potency and 121 registered trials.
One query, EGFR gefitinib, returns IC50 binding measurements, trial counts and CIViC evidence for the pair from three resources, as of 2026-11-06.